UK markets closed

Inogen, Inc. (INGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.07+0.10 (+1.32%)
At close: 04:00PM EDT
8.07 0.00 (0.00%)
After hours: 04:02PM EDT

Inogen, Inc.

859 Ward Drive
Goleta, CA 93111
United States
805 562 0500
https://www.inogen.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees834

Key executives

NameTitlePayExercisedYear born
Mr. Jason SomerExecutive VP, General Counsel & Corporate Secretary409.92kN/A1968
Dr. Stanislav Glezer M.D., MBAExecutive VP of R&D and Chief Medical Officer575.8kN/A1973
Mr. Kevin R. M. SmithPresident, CEO & DirectorN/AN/A1971
Mr. Michael J. BourqueExecutive VP, CFO & TreasurerN/AN/A1963
Mr. Philip CorrinSenior Vice President of Operations & Supply ChainN/AN/AN/A
Ms. Jennifer Yi BoyerExecutive VP & Chief Human Resources OfficerN/AN/AN/A
Mr. Vijay PaliwalSenior Vice President of Enterprise EnablementN/AN/AN/A
Mr. Grgoire RamadeExecutive VP & Chief Commercial OfficerN/AN/A1970
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Corporate governance

Inogen, Inc.’s ISS governance QualityScore as of 1 March 2024 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.